A 15
Pill imprint A 15 has been identified as Simvastatin 5 mg.
Simvastatin is used in the treatment of high cholesterol; high cholesterol, familial heterozygous; high cholesterol, familial homozygous; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia (and more), and belongs to the drug class statins. Not for use in pregnancy.
Simvastatin 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Simvastatin Images
- Imprint:
-
A
15 - Strength:
- 5 mg
- Color:
- Yellow
- Size:
- 5.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- ascorbic acid
lactose monohydrate
microcrystalline cellulose
corn starch
hydroxypropyl cellulose
hypromellose 2910 (6 mPa.s)
titanium dioxide
magnesium silicate
citric acid monohydrate
isopropyl alcohol
magnesium stearate
butylated hydroxyanisole
ferric oxide yellow
- Drug Class:
- Statins
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0050
| NDC Code | Manufacturer / Repackager |
|---|---|
| 16714-0681 | Northstar Rx |
Note: Inactive ingredients may vary.
More Simvastatin resources
- Simvastatin
- Simvastatin (Wolters Kluwer)
- simvastatin (Cerner Multum)
- simvastatin (Micromedex) - Includes Dosage Information
- Simvastatin (AHFS DI)
- Simvastatin (FDA)
- Simvastatin orally disintegrating tablet (FDA)
- Simvastatin (Wolters Kluwer)
Simvastatin is associated with the treatment of:
- Cardiovascular Risk Reduction
- High Cholesterol
- High Cholesterol, Familial Heterozygous
- High Cholesterol, Familial Homozygous
- Hyperlipoproteinemia
- Hyperlipoproteinemia Type IIa, Elevated LDL
- Hyperlipoproteinemia Type IIb, Elevated LDL VLDL
- Hyperlipoproteinemia Type III, Elevated beta-VLDL IDL
- Hyperlipoproteinemia Type IV, Elevated VLDL


